Evonik Industries (EVK) PT Set at €39.00 by Societe Generale
Evonik Industries (FRA:EVK) received a €39.00 ($46.43) price target from analysts at Societe Generale in a research note issued to investors on Thursday. The firm presently has a “buy” rating on the stock. Societe Generale’s price objective points to a potential upside of 24.12% from the stock’s previous close.
Several other research analysts have also recently weighed in on EVK. Barclays set a €34.50 ($41.07) target price on Evonik Industries and gave the company a “buy” rating in a research note on Friday, September 29th. UBS Group set a €27.00 ($32.14) target price on Evonik Industries and gave the company a “sell” rating in a research note on Monday, January 8th. Deutsche Bank set a €32.00 ($38.10) target price on Evonik Industries and gave the company a “neutral” rating in a research note on Thursday, September 28th. Credit Suisse Group set a €34.30 ($40.83) target price on Evonik Industries and gave the company a “buy” rating in a research note on Tuesday, September 26th. Finally, Warburg Research set a €38.70 ($46.07) target price on Evonik Industries and gave the company a “buy” rating in a research note on Wednesday. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and eleven have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of €33.87 ($40.32).
Shares of Evonik Industries (EVK) traded up €0.39 ($0.46) during mid-day trading on Thursday, reaching €31.42 ($37.40). The company had a trading volume of 537,379 shares. Evonik Industries has a fifty-two week low of €26.78 ($31.88) and a fifty-two week high of €32.97 ($39.25). The company has a market capitalization of $14,630.00 and a PE ratio of 20.01.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.